Nevertheless, further work is required to delineate the role of a specific cell type within the liver or by CB1R located intracellularly within these cells, and to determine the effectiveness of CB1R blockade in improving hepatic steatosis and the insulin resistance. This evidence concerns the gene CNR1 and fatty liver disease.